EUVIMEDEUVIMED entdecken
Crossref

Species Distribution and Antimicrobial Susceptibility of Diverse Strains Within Burkholderia cepacia Complex

Ke Li, Huiqiong Jia, Yaxi Gu, Yanyan Xiao, Shengchao Li, Yahong Qu, Qing Yang

Microbial Drug Resistance · 2025

DOI: 10.1089/mdr.2024.0220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Drug Resistance, 2025. Verfasst von Ke Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratories, The Second Hospital of Yinzhou, Ningbo, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Burkholderia cepacia complex, Burkholderia Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The aim of the present study was to examine the clinical distribution and antibiotic susceptibility of the Burkholderia cepacia complex (BCC).

Methods

The BCC clinical strains were obtained from the First Affiliated Hospital of Zhejiang University School of Medicine in China from January 2019 to January 2024, and hisA gene sequencing was employed for strain identification. The in vitro susceptibility of various antibacterials was measured through the disk diffusion method and the broth microdilution method.

Results

A total of 386 strains of BCC were collected. Among them, the most common strains were B. cenocepacia (45.9%), B. multivorans (45.1%), and B. contaminans (7.0%). B. multivorans was the main one in respiratory specimens, whereas B. cenocepacia dominated in blood specimens. B. cenocepacia , B. multivorans , and B. contaminans exhibited a susceptibility over 95% to meropenem and sulfamethoxazole–trimethoprim, whereas varying sensitivities were displayed to levofloxacin, ceftazidime, and minocycline ( p < 0.05). Among tetracyclines, eravacycline exhibited the lowest minimum inhibitory concentration 90 (MIC90) values 1 µg/mL for B. cenocepacia , 1 µg/mL for B. multivorans , and 2 µg/mL for B. contaminans . This was followed by tigecycline (MIC90: 2 µg/mL, 2 µg/mL, and 4 µg/mL, respectively), minocycline (MIC90: 8 µg/mL, 2 µg/mL, and 8 µg/mL, respectively), and omadacycline (MIC90: 8 µg/mL, 4 µg/mL, and 16 µg/mL, respectively). Compared with the broth microdilution method, the category agreement (CA) of sulfamethoxazole–trimethoprim and ceftazidime was >95%, and the very major error was

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBurkholderia cepacia complexBurkholderia InfectionsHumansMicrobial Sensitivity TestsChinaDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

Burkholderia cepacia complexantimicrobial susceptibilityclinical distributiontetracyclines

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Clinical Laboratories, The Second Hospital of Yinzhou, Ningbo, China.
  • Department of Clinical Laboratories, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Zitieren

APA

Li, K., Jia, H., Gu, Y., Xiao, Y., Li, S., Qu, Y., & Yang, Q. (2025). Species Distribution and Antimicrobial Susceptibility of Diverse Strains Within Burkholderia cepacia Complex. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2024.0220

Vancouver

Li K, Jia H, Gu Y, Xiao Y, Li S, Qu Y, et al. Species Distribution and Antimicrobial Susceptibility of Diverse Strains Within Burkholderia cepacia Complex. Microbial Drug Resistance. 2025. doi:10.1089/mdr.2024.0220

BibTeX
@article{Li2025,
  author = {Li, Ke and Jia, Huiqiong and Gu, Yaxi and Xiao, Yanyan and Li, Shengchao and Qu, Yahong and Yang, Qing},
  title = {Species Distribution and Antimicrobial Susceptibility of Diverse Strains Within Burkholderia cepacia Complex},
  journal = {Microbial Drug Resistance},
  year = {2025},
  doi = {10.1089/mdr.2024.0220}
}
Kostenlos starten →